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Abstract
Introduction:  Segmental ostial pulmonary vein   isolation (PVI) is considered a potentially 
curative therapeutic approach in the treatment of paroxysmal atrial fibrillation (PAF). There is 
only   limited   data   available   on   the   long-term   effect   of   this   procedure.  
Methods: Patients (Pts) underwent a regular clinical follow up visit at 3, 6 and 24 months after 
PVI.   Clinical   success   was   classified   as   complete   (i.e.   no   arrhythmia   recurrences,   no 
antiarrhythmic drug), partial (i.e. no/only few recurrences, on drug) or as a failure (no benefit). 
The clinical responder rate (CRR) was determined by combining complete and partial success. 
Results: 117 patients (96 male, 21 female), aged 51±11 years (range 25 to 73) underwent a total 
of 166 procedures (1.4/patient) in 2-4 pulmonary veins (PV). 115 patients (98%) had AF, 2 
patients presented with  regular PV atrial tachycardia. ,109/115 patients. exhibited PAF as the 
primary arrhythmia (versus persistent AF). A total of 113 patients with PVI in the years 2001 to 
2003 were evaluated for their CRR after 6 (3) months. A single intervention was carried out in 
63 patients (55.8%), two interventions were performed in   45 patients (39.8%) and three 
interventions in 5 patients (4.4%). The clinical response demonstrated a complete success of  
52% (59 patients), a partial success of 26% (29 patients) and a failure rate of 22% (25 patients), 
leading to a CRR of 78% (88 patients). Ostial PVI in all 4 PVs exhibited a tendency towards 
higher curative success rates (54% versus 44% in patients with 3 PVs ablated for the 6 month 
follow up). Long-term clinical outcome was evaluated in 39 patients with an ablation attempt at 
3 PVs only (excluding the right inferior PV in our early experience) and a mean clinical follow 
up of  21±6 months. At this point in time the success rate was 41% (complete, 16 patients) and 
21% (partial, 8 patients), respectively, adding up to a CRR of 62% (24 patients). In total, 20 
patients (17.1%) had either a single or 2 (3 patients, 2.6%) complications independent of the 
number of procedures performed with PV stenosis as the leading cause (7.7%).                   
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Conclusion: The CRR of patients with medical refractory PAF in our patient cohort is 78% at 
the 6 month follow up. PV stenosis is the main cause for procedure-related complications.  
Ablation of all 4 PV exhibits a tendency towards higher complete success rates despite equal 
CRR. Calculation of the clinical response after a mid- to long-term follow of 21±6 months in 
those patients with an ostial PVI in only 3 pulmonary veins (sparing the right inferior PV) shows 
a further reduction to 62%, exclusively caused by a drop in patients with a former partial 
success.  To evaluate the long-term clinical benefit of segmental ostial PVI in comparison with 
other ablation techniques, more extended follow up periods are mandatory, including a larger 
study   cohort   and   a   detailed   description   of   procedural   parameters.                            
            
Keywords:  atrial fibrillation; pulmonary vein ablation                                                                 
Introduction
            Based on groundbreaking work by Michel Haissaguerre et al. a catheter-based procedure 
was   recently   introduced   into   clinical   routine   to   treat   drug-refractory   paroxysmal   atrial 
fibrillation (PAF)1,2. During segmental ostial pulmonary vein isolation (PVI),   electrically 
conducting myocardial extensions bridging the pulmonary veins (PV) with the posterior wall of 
the left atrium (LA) are disconnected to prevent the initiation (and the maintenance) of PAF. 
            Success rates reported in recent literature differ to a big extent (between 50 and 90%)3,4 
and are not always comparable, as applied techniques may vary considerably and are changing 
with growing experience in the same group. Moreover, evaluation of success is not consistent 
within published reports, as clinical judgement of ablation outcome may be difficult to determine 
(missing ECG documentation in symptomatic periods, asymptomatic episodes). In addition, 
follow up periods are rarely comparable and sometimes are rather short, so that there is still a 
lack of data addressing the long-term outcome in ablation of the PV ostia to treat PAF 
nowadays.  
            We have reported on our early experience in the past5. In this paper we report on our own 
short and long-term results with special consideration of distinct procedural parameters which 
have been developed in a time period of three years from 2001 to 2004.                              
Patients and Methods                                                                                                                   
Lasso Procedure                                                                                                             
            Briefly, after puncture of one (or both) femoral and the left subclavian (in case the 
coronary sinus can not be entered by a femoral access) vein(s) a multipolar electrode catheter is 
introduced in the coronary sinus to record left atrial activity. Thereafter, a (usually double) 
transseptal puncture is performed followed by pulmonary venography. Next, two electrode 
catheters are placed in the LA via two long sheaths, one for ablation  (Celsius THERMOCOOL 
7F, Biosense Webster, Inc.) and one circular decapolar catheter (“Lasso”, Biosense Webster, 
Inc.) to record electrical activity of myocardial extensions connecting  the LA with a PV. The 
lasso catheter is situated as proximal as possible inside the PV whereas the ablations catheter is 
positioned at the very os to segmentally isolate the PV, thereby preventing  stenosis which may 
occur when delivering energy deep inside a PV. Electrical entrance block from the LA to the PV 
is considered as the endpoint of the procedure which is documented by the elimination of PV 
potentials on the Lasso catheter. We have been using irrigated ablation catheters from the very 
beginning of our PV ablation experience, delivering up to 30 Watts of energy in the superior 
PVs (left superior, LSPV and right superior, RSPV) and a maximum of 20-25 Watts in the 
inferior PVs (left inferior, LIPV and right inferior, RIPV). The approach of targeting a PV for 
ablation is “empiric” i.e. independent of its arrhythmic activity during the time of the procedure. 
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In the time period from 2001 to the first half of 2002, 3 PVs were routinely isolated, whereas 
since then all 4 PVs (including the RIPV which is sometimes more difficult to reach) were 
targeted   during   a   single   procedure.                                                          
Follow   up                                                                                              
            In the following we report on our experience in ostial PVI in the time period between 
12/2000 and 02/2004. The last follow up visit was performed in 04/2004. After the procedure, 
patients were monitored on an outpatient basis after one month and on an inpatient basis after 3, 
6 and approximately 24 months. The following tests were routinely performed: Clinical 
examination, Holter-ECG, evaluation of quality of life using a standardized questionnaire, in 
addition (on an inpatient basis)  transthoracic and transesophageal echocardiography, stress test, 
spiral computed tomography (CT) of the PVs, and (only in case of significant PV stenosis) 
magnetic resonance imaging of the PV and a lung scan.                                                              
Success criteria                                                                                                       
            Two distinct time periods were analyzed in order to evaluate the clinical outcome: a short 
term follow up period of 6 months (3 months for the last patients in this series) and a long-term 
follow up of approximately 24 months. The clinical outcome was classified as complete success 
(CS) if patients were without any documented arrhythmias and free of antiarrythmic medication. 
A partial success (PS) was defined by an absence of clinical symptoms while patients being still 
on an antiarrhythmic drug. These two groups comprised the patient cohort for which the clinical 
response rate (CRR) was calculated. A clinical failure (CF) was classified as such in the rest of 
patients who showed no benefit while usually still on drug.                                                  
     
Results
Demographics
            117 patients (96 male, 21 female) aged 51±11 years (range 25-73 years) were included 
for chronic follow up. 26 patients (22%) had an underlying heart disease (hypertension n=18, 
coronary artery disease n=4, diabetes n=4); 2 patients had a history of a transient ischemic 
cerebral attack. Patients had used a mean number of 3.1±1.4 antiarrhythmic drugs. In most 
instances several class I, II and class III drugs had been administered previously (propafenone 
70%, betablocker 65%, amiodarone 56%, sotalol 51%, flecainide 26%); uncommonly, class IV 
drugs (verapamil in 18% and digoxin in 14%).                                                                           
Arrhythmia characteristics
            Arrhythmia history showed a wide inter-individual variation and lasted for 73±67 months 
(median 48 months), the maximal episode duration within the last 3 months had a median of 390 
min, the mean number of arrhythmia recurrences acccounted for n=2/week. Table 1 illustrates 
the classification of the preexisting arrhythmia as defined by the surface ECG. 115/117 patients 
(98%) exhibited AF as their primary clinical atrial tachyarrhythmia with 86 presenting only with 
PAF, 10 showing additional regularized atrial tachycardias, 14 typical atrial flutter and 5 patients 
presenting both types, respectively. The majority of patients (109/115, 94.7%) presented with 
PAF, 6/115 (5.3%) showed only persisting AF . Two patients (1.6%) exhibited nearly incessant 
“P on T” atrial runs suggesting a pulmonary venous origin which was reconfirmed  during the 
ablation procedure. These 2 patients underwent pulmonary venous segmental ostial ablation and 
therefore were both included in this analysis.
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Table 1: Classification of the preexisting arrhythmia (AF=atrial fibrillation)
 
Procedures
            166 procedures (1.42/patient) in 2-4 PVs were performed in total, consisting of 117 
(71%) primary, 44 (27%) secondary und 5 (2%) tertiary procedures. Figure 1 illustrates the 
respective numbers of primary, secondary and tertiary procedures per patient and year (of first 
procedure) between 2001 and 2003. In 63 patients (55.8%) a single procedure was carried out, as 
opposed to 45 patients (39.8%) with a second and 5 patients (4.4%) with a third ablation 
procedure. The duration of the primary procedure lasted for 228±55 min and was significantly 
longer in comparison with the secondary (206±56 min, p=0.004). The fluoroscopic time duration 
for the primary and secondary procedure accounted for 62±15min, and 53±20min, respectively. 
Figure 1: Relative percentage of primary, scondary and teriary procedures per patient and per 
year of ablation (of the primary procedure) 
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            In most of the patients the LSPV (96%), LIPV (96%) and the RSPV (95%) were isolated 
ostially, whereas the RIPV was targeted in only 55%. The reason for this is that this PV is 
usually more difficult to reach and was spared in our early ablation experience from 2001 to the 
first half of the year 2002. Consequently, the number of patients with PVI in 3PVs, 4 PVs or 2 
PVs   accounted   for   40   %   (n=47),   54%   (n=63)   and   6%   (n=7),   respectively.  
Success  rates                                                                                                     
            113 patients were evaluated for the determination of the clinical outcome after 6 months 
(after 3 months only in 8/113 patients with a limited follow up). CRR accounted for 78% (88 
patients) consisting of  52% CS (59 patients), 26% PS (29 patients) und 22% CF (25 patients), 
respectively (Figure 2). CS was higher in patients undergoing PVI in 4 PVs versus PVI in 3 PVs 
(54% versus 44%) (Figure 3). However, the CRR was similar in both groups (77% in 4 PVs and 
78% in 3 PVs, respectively).
            For the determination of the long term succes rate after a mean of 21±6 months only 
those patients with PVI in 3 PVs (sparing the RIPV) were evaluated. For a total of 39 patients 
the CS, PS and CF rates accounted for 41% (n=16), 21% (n=8), 38% (n=15), respectively, 
leading to a CRR of 62% (n=24). Considering only this group of 39 patients for their specific 
clinical course after 6 months separately, CS, PS and CF rates account for  41% (n=16), 33% 
(n=13) and 26% (n=10), respectively, leading to a CRR of  74% (n=29) (Figure 2). From these 
results one may conclude that CRR in the longterm follow up is reduced by a reduction in PS, 
however, the CS rate seems stable even in the long run.                                             
            The clinical success rates per year of experience are depicted in Figure 4. As patients 
had to have all procedures performed within a single year for this analysis, the number of 
patients evaluated decreases to n=103.  
Figure 2: Success rates in the short- and longterm follow up period 
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Figure 3: Success rates in a 3 versus a 4 PV approach (including the RIPV)
Figure 4: Success rates per year of ablation performed  
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Complications
            Significant PV stenoses are the leading cause of side effects in the longterm follow up 
ranging up to 7.7% (n=9), all other complications account for less than 1.5%, such as pericardial 
tamponade (n=2), pericardial effusion (n=2), stroke (n=2), pneumo-/hemothorax (n=2), groin 
hematoma (n=2) and pericarditis (n=1). In total,  20 patients (17.1%) had either a single or 2 (3 
patients,   2.6%)   complications   independent   of   the   number   of   procedures   performed.   
Discussion
            We have reported repeatedly on our experience in ostial PVI recently, in particular on the 
occurence of PV stenosis6,7 , quality of life8 and the evaluation of procedural success by use of 
longterm implantable monitoring provided by special implantable pacemakers with extended 
storage   capabilities   in   chronically   paced   patients9.                                     
            In this paper our data highlight the potentially curative therapeutic approach of segmental 
ostial PVI over a short- and longterm follow up in a patient cohort with highly symptomatic and 
medically drug-refractory  recurrent PAF and without significant underlying heart disease. In 
total, 78% of patients show a clinical benefit over a follow up period of 6 months, which is 
reduced to 62% in the long-term after approximately 24 months in a patient cohort that 
underwent PVI in 3 PVs (sparing the RIPV). An ablation procedure that includes PVI in the 
RIPV as well exhibits a higher curative success rate after 6 months of follow up (54% versus 
44%).
Segmental   ostial   PVI                                                                              
            According to current knowledge, a segmental ostial ablation approach at the PV-LA 
junction represents a predominant trigger elimination of ectopic foci from within the PVs 
capable of initiating PAF by rapid focal discharges. To which extent an ongoing fibrillatory 
process in the LA may be maintained by such PV discharges remains an open issue at this point 
in time10. In addition, ectopic activity that may trigger PAF may also be generated at different 
sites in both atria (posterior and anterior LA, coronary sinus, terminal crest, superior caval vein). 
This may well explain why a 100% cure rate is unlikely when applying radiofrequency ablation 
at the ostial level of the PVs solely.  
Procedural   parameters                                                                        
            Despite the fact that the arrhythmogenic potential of the RIPV was somewhat in doubt 
years ago, our results are in accordance with other more recent reports in the literature 
demonstrating the importance of implementing this PV in the ablation procedure. As illustrated 
in figure 3 the CS is higher when isolating all 4 PVs (versus 3 PVs). The RIPV is sometimes 
more difficult to reach technically, however, with improved catheter steerability  this problems is 
solved most of the time nowadays. Other procedural parameters do not seem crucial in our series 
as our approach of isolating the PVs did not change over the years using the same diagnostic 
catheter (Lasso catheter) within the PV ostium and a stable energy source for ablation 
(radiofrequency ablation with irrigated catheters) with unchanged energy settings (30 Watts for 
the superior PVs and 20-25 Watts for the inferior PVs).                                               
Longterm   success   rate                                                                        
            Our longterm success rates after approximately 24 months may be limited by the fact that 
these results represent the outcome in patients having undergone ostial PVI in 3 PVs exclusively. 
If we compare the longterm success rate of this separted group with its 6 month follow up data, 
it is obvious that the CS is literally idenitical  (41%) whereas the PS and the CRR seem to be 
somewhat higher on a short term basis (33% versus 21% and 74% versus 62%, respectively). 
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Our results demonstrating a stable cure rate over an extendend period are confirmed in a 
previously published larger report11. However, it remains interesting to reconfirm those data by 
our own series of patients having undergone a 4 PV ablation approach from the second half ot 
the   year   2002   onwards.                                                                    
Learning   curve                                                                                
            To find an appropriate measure for our learning curve we have analyzed the number of 
secondary procedures and the success rates . As depicted in figure 1 there is a constant decrease 
of secondary procedures per patient with growing experience : The percentage decreases from 
about 50% in patients with their primary procedure in the year 2001 to 40% and 25%, 
respectively in patients who underwent PVI in the year 2002 and 2003. The reason for this is 
based on the growing knowledge about the nature of early recurrences (within the first days after 
the primary procedure): As those recurrences may merely represent transient effects of leason 
healing we tended to treat those arrhythmias conservatively with growing experience by 
administering antiarrhythmic drugs instead of performing an early redo procedure. In addition , 
we were able to exactly quantify and publish the decrease of arrhythmic burden of PAF within 
the first 3 months after PVI in 12 patients who were previously implanted with a last generation 
implantable pacemaker offering extended storage capabilities (Medtronic Inc, AT 500)9. Figure 
4 demonstrates  the success rate based on the year of the primary procedure. It shows an increase 
in the CS from 40% in the year 2001 to about 50% in the next two years. The most likely cause 
for this is the fact that the procedure changed from a 3 PV to a 4 PV isolation approach  
(including the RIPV) . The CRR, however, remains fairly constant, reaching 70 to 80%.  
Redo procedures                                                                                                                     
            In general, concomitant atrial tachycardias or atrial flutter were not a primary target for 
ablation during the first ablation session. In case of a recurrence of PAF, one or more PVs were 
usually reconnected and had to be reisolated. In addition, sustained atrial tachycardias as well as 
right or left atrial flutter circuits were mapped as appropriate. However, no detailed ablation 
results   for   these   substrates   are   available   in   this   reported   patient   series.
Complications
            With regard to diagnosis, management and outcome in PV stenosis follwing ostial PVI 
we may refer to our previously published results6,7. Despite the fact that there may be multiple 
factors operational for the occurence of PV stenosis (energy source, amount of delivered energy, 
localisation of the affected PV) the exact site of energy delivery at the ostial level seems to be of 
highest importance: The more energy delivered within a PV (versus ostial) the higher the chance 
of developing significant PV stenosis. In general, the symptom threshold (including dyspnea, 
hemoptysis and pneumonia) for significant PV narrowing exceeds 60% of luminal narrowing, 
however, not every single significant PV narrowing produces symptoms. Lung scanning is a 
useful diagnostic test to document hemodynamically significant PV stenosis by detecting a 
segmental perfusion deficit. Interventions in significant PV stenosis including PV dilatation 
and/or stenting may lead to a high reocclusion rate. In our published series of 6 patients with 
predominant single PV stenosis the clinical outcome is beneficial despite reocclusion in 2 
patients during a longterm follow up.                                                              
Limitations
            Longterm success is based on the results in patients with a 3 PV ostial isolation approach 
(sparing the RIPV). It may well be that chronic results in patients with a 4 PV (including the 
RIPV) approach are superior.                                                                                                                 
            Although routine longterm ECG monitoring was performed at prespecified points in time 
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during follow up,   clinical success is primarily based on symptomatic episodes of PAF. It 
remains unclear who often and to what extent silent episodes of PAF may have changed the 
clinical   results of PVI in our patient subgroups.                                                                 
 
Future outlook                                                                                                     
            According to many other working groups worldwide we have changed our ablation 
strategy recently: Using a 3 dimensional mapping system (CARTO, Biosense Webster Inc.) an 
electroanatomic map of the LA including the mitral valve annulus and the PVs is reconstructed 
pre ablation. Thereafter, periostial circumferential atrial lesions are deployed around the septal 
and lateral PVs in order to modify the substrate of PAF (Figure 5). In addition, an ablation line 
in between the LIPV and the mitral valve is drawn (socalled „mitral isthmus“), which is at times 
accompanied by a roof line in the LA connecting the superior PVs. It seems critical to attain 
complete lesion sets designed to prevent the spread of focal discharges from withhin the PV to 
the rest of the LA (Pappone approach12).  At this point in time we are still using a multipolar 
circular catheter to be located at the ostial level to monitor and guide PV isolation at the LA-PV 
junction. Recently published reports demonstrate higher success rates using circumferential PV 
atrial ablation in contrast to segmental ostial PVI both in PAF13 and (even more) in persistent to 
permanent forms of AF. An additional advantage of this technique is based on the diminished 
occurence of PV stenoses by applying energy >1cm away from the ostial level. However, 
additional point lesions at the ostial level of a PV are often required to accomplish complete LA-
PV block. 
    
a                                                                                     b
Figure 5: Elecroanatomical Mapping (CARTO): the red dots are representing ablation spots 
a) Anteroposterior projection,  b) posteroranterior projection
            In the meantime a multislice CT imaging modality is available in our institution which 
enables the 3 dimensional representation of a patient´s individual cardiac anatomy (Figure 6). In 
addition,   worldwide   intensive   collaboration   within   different   manufacturers   of   cardiac 
visualization systems is ongoing to enable "3 D image integration"  which will allow a direct 
transfer of imaging files to the mapping system at work. By this, a direct transfer of the 
individual electrical activation to the individual patient´s anatomy seems feasible ("image 
guiding“).  
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            Moreover, interesting and promising efforts are made by one manufacturer (Stereotaxis, 
Inc) to conduct an ablation procedure by remote navigation of the ablation catheter which is 
directed by a strong magnetic field around the patient´s body.    
Figure 6: Multislice CT demonstrating aortic (above), pulmonary arterial (mid) and pulmonary 
venous vasculature (posterioanterior projection)
Conclusion
            The CRR in patients with medically refractory PAF undergoing ostial PVI accounts for 
78% after a short term follow up of 6 months. A 4 PV procedure (including the RIPV) warrants 
a higher CS. In patients with a 3 PV procedure (sparing the RIPV) the CRR in the longterm 
follow up is reduced to 62%. However, the CS rate seems to be constant, whereas the PS is 
reduced. PV stenosis is the main cause for complications. In addition to an exact analysis of 
procedural parameters a longer follow up period seems necessary to better quantify the clinical 
benefit to risk ratio of segmental ostial PVI in contrast to other strategies in the treatment of 
atrial fibrillation. 
References
1. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic 
beats   originating   in   the   pulmonaty   veins.   N   Engl   J   Med   1998;339:659-666.
2. Haissaguerre M, Shah DC, Jais P et al. Electrophysiological breakthroughs from the left 
atrium to the pulmonary veins. Circulation 2000;102:2463-2465.
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 6(1): 6-16 (2006)Pürerfellner H., Aichinger J., Martinek M., Nesser H.J., Janssen J,                               16 
“Short-   and   long-term   experience   in   pulmonary   vein   segmental   ostial   ablation   for 
paroxysmal atrial fibrillation”
3.  Karch MR, Zrenner B, Deisenhofer I, et al. Freedom from atrial tachyarrhythmias after 
catheter ablation of atrial fibrillation. A randomized comparison between 2 current ablations 
strategies. Circulation 2005;111:2875-2880.
4.  Pappone C, Rosanio S, Augello G, et al. Mortality, morbidity, and quality of life after 
circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled non-
randomized long-term study. J Am Coll Cardiol 2003;42:185-197.
5.  Pürerfellner   H,   Aichinger   J,   Nesser   HJ.   Segmentale   ostiale   Katheterablation   der 
Pulmonalvenen bei paroxysmalem Vorhofflimmern: Ergebnisse nach einjähriger Erfahrung. J 
Kardiol 2002;9(11):497-505.
6. Pürerfellner H, Cihal R, Aichinger J et al. Pulmonary vein stenosis by ostial irrigated tip 
ablation: incidence, time course and prediction. J Cardiovasc Electrophysiol 2003;14: 1-7.
7.  Pürerfellner H, Aichinger J, Martinek M, et al. Incidence, management and outcome in 
significant pulmonary vein stenosis complicating ablation for atrial fibrillation. Am J Cardiol 
2004;93: 1428-1431.
8.  Pürerfellner H, Martinek M, Aichinger J, et al. Quality of life restored to normal in patients 
with atrial fibrillation after pulmonary vein ostial isolation. Am Heart J 2004;148:318-325.
9. Pürerfellner H, Aichinger J, Martinek M, et al. Quantification of atrial tachyarrhythmia burden 
with an implantable pacemaker before and after pulmonary vein isolation. PACE 2004;27:1277-
1283.
10. Oral H, Ozaydin M, Tada H, et al. Mechanistic significance of intermittent pulmonary vein 
tachycardia in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2002;13:645-650.
11. Oral H, Veerareddy S, Good E, et al. Prevalence of asymptomatic recurrences of atrial 
fibrillation  after   successful  radiofrequency  catheter   ablation.  J   Cardiovasc  Electrophysiol 
2004;15:920-924.
12.  Pappone   C,   Oreto   G,   Rosiano   S,   et   al.   Atrial   electroanatomic   remodeling   after 
circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a 
large cohort of patients with atrial fibrillation. Circulation 2001;104:2539-2544.
13.  Oral H, Scharf C, Chugh A, et al. Catheter ablation for paroxysmal atrial fibrillation: 
segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation 2003;108:2355-
2360.
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 6(1): 6-16 (2006)